Agios Pharmaceuticals, Inc.: Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease

NDA submission follows agreement with FDA on confirmatory trial, a requirement of the accelerated approval pathway Confirmatory trial designed to demonstrate clinical benefit of mitapivat on reducing ...
The Canadian Press on MSN

Fact File: Looksmaxxing methods meant to change facial structure are harmful: experts

"Bone smashing is amazing," the square-jawed social media influencer Braden Peters, known online as Clavicular, boasts in a November 2025 livestream appearance.

Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias

Detailed results from RISE UP Phase 3 trial of mitapivat in sickle cell disease selected for distinguished Plenary Abstracts SessionCompany to ...
OSTechNix

JavaScript Timestamp Bugs: How UTC Mistakes Break Web Apps

Learn how a single JavaScript Date() timezone mistake silently corrupts web apps and how to fix timestamp bugs in JS, Python, ...